Solum And 2 Other Growth Companies Insiders Are Betting On

As global markets experience broad-based gains, with U.S. indexes approaching record highs and smaller-cap indexes outperforming large-caps, investor optimism is buoyed by strong labor market reports and rising home sales. Amidst this positive sentiment, growth companies with high insider ownership are attracting attention as insiders demonstrate confidence in their businesses despite geopolitical uncertainties. In the current market environment, stocks with significant insider ownership may be appealing due to the alignment of interests between company leaders and shareholders.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Seojin SystemLtd (KOSDAQ:A178320)	31.1%	43.2%
Kirloskar Pneumatic (BSE:505283)	30.3%	26.3%
Archean Chemical Industries (NSEI:ACI)	22.9%	41.3%
SKS Technologies Group (ASX:SKS)	32.4%	24.8%
Laopu Gold (SEHK:6181)	36.4%	34.2%
Medley (TSE:4480)	34%	31.7%
Findi (ASX:FND)	34.8%	71.5%
Elliptic Laboratories (OB:ELABS)	26.8%	103.6%
Fulin Precision (SZSE:300432)	13.6%	66.7%
Brightstar Resources (ASX:BTR)	16.2%	84.6%

Click here to see the full list of 1514 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Solum (KOSE:A248070)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Solum Co., Ltd. is a company that produces and sells power modules, digital tuners, and electronic shelf labels both in South Korea and globally, with a market capitalization of approximately ₩1.03 trillion.

Operations: The company's revenue is derived from two main segments: the ICT Business, contributing ₩432.21 million, and the Electronic Components Division, generating ₩1.14 billion.

Insider Ownership: 16.6%

Earnings Growth Forecast: 53.2% p.a.

Solum's earnings are projected to grow significantly at 53.17% annually, surpassing the KR market average of 29.3%. Despite a decrease in profit margins from 5.8% to 2.8%, the company is trading at a substantial discount, approximately 40.6% below its fair value estimate. Recent share buybacks amounting to KRW 3,356.47 million highlight ongoing capital management efforts, although insider trading activity has been minimal over the past three months.

• Click to explore a detailed breakdown of our findings in Solum's earnings growth report.
• Our expertly prepared valuation report Solum implies its share price may be lower than expected.

Stadler Rail (SWX:SRAIL)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Stadler Rail AG, with a market cap of CHF1.92 billion, manufactures and sells trains across Switzerland, Germany, Austria, Europe, the Americas, CIS countries, and other international markets.

Operations: The company's revenue segments include Signalling with CHF135.68 million, Rolling Stock contributing CHF3.10 billion, and Service & Components generating CHF789.41 million.

Insider Ownership: 14.5%

Earnings Growth Forecast: 22.9% p.a.

Stadler Rail's earnings are forecast to grow significantly at 22.94% annually, outpacing the Swiss market average of 11.4%. Despite a volatile share price recently, the company is trading at a substantial discount, approximately 48.3% below its fair value estimate. However, its dividend yield of 4.69% is not well covered by free cash flows. No significant insider trading activity has been reported in the past three months.

• Navigate through the intricacies of Stadler Rail with our comprehensive analyst estimates report here.
• Upon reviewing our latest valuation report, Stadler Rail's share price might be too pessimistic.

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates as an online pharmacy across several European countries including the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of approximately €3 billion.

Operations: The company's revenue is divided into two main segments: DACH, which generated €1.82 billion, and International, which brought in €410.50 million.

Insider Ownership: 17.2%

Earnings Growth Forecast: 61.5% p.a.

Redcare Pharmacy's revenue is forecast to grow at 17.6% annually, surpassing the German market average of 5.6%. The company recently raised its sales guidance for 2024, expecting between €2.35 billion and €2.5 billion in total sales, despite reporting a net loss of €18.98 million for the first nine months of the year. Trading significantly below its estimated fair value, Redcare is projected to achieve profitability within three years with earnings growth at 61.52% annually.

• Delve into the full analysis future growth report here for a deeper understanding of Redcare Pharmacy.
• According our valuation report, there's an indication that Redcare Pharmacy's share price might be on the expensive side.

Seize The Opportunity

• Get an in-depth perspective on all 1514 Fast Growing Companies With High Insider Ownership by using our screener here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com